Literature DB >> 29407467

Neuroprotective effects of voluntary running on cognitive dysfunction in an α-synuclein rat model of Parkinson's disease.

Erin K Crowley1, Yvonne M Nolan2, Aideen M Sullivan3.   

Abstract

Parkinson's disease (PD) is no longer primarily classified as a motor disorder due to increasing recognition of the impact on patients of several nonmotor PD symptoms, including cognitive dysfunction. These nonmotor symptoms are highly prevalent and greatly affect the quality of life of patients with PD, and so, therapeutic interventions to alleviate these symptoms are urgently needed. The aim of this study was to investigate the potential neuroprotective effects of voluntary running on cognitive dysfunction in an adeno-associated virus-α-synuclein rat model of PD. Bilateral intranigral administration of adeno-associated virus-α-synuclein was found to induce motor dysfunction and a significant loss of nigral dopaminergic neurons, neither of which were rescued by voluntary running. Overexpression of α-synuclein also resulted in significant impairment on hippocampal neurogenesis-dependent pattern separation, a cognitive task; this was rescued by voluntary running. This was substantiated by an effect of running on neurogenesis levels in the dorsal dentate gyrus, suggesting that the functional effects of running on pattern separation were mediated via increased neurogenesis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognition; Exercise; Neurogenesis; Nonmotor symptoms; Parkinson's disease; α-synuclein

Mesh:

Substances:

Year:  2018        PMID: 29407467     DOI: 10.1016/j.neurobiolaging.2018.01.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

Review 1.  Convergent pathways of the gut microbiota-brain axis and neurodegenerative disorders.

Authors:  Carolina Gubert; Juciano Gasparotto; Livia H Morais
Journal:  Gastroenterol Rep (Oxf)       Date:  2022-05-16

Review 2.  Motor Dysfunction in REM Sleep Behavior Disorder: A Rehabilitation Framework for Prodromal Synucleinopathy.

Authors:  Rebekah L S Summers; Miriam R Rafferty; Michael J Howell; Colum D MacKinnon
Journal:  Neurorehabil Neural Repair       Date:  2021-05-12       Impact factor: 3.919

3.  Osteocalcin Ameliorates Motor Dysfunction in a 6-Hydroxydopamine-Induced Parkinson's Disease Rat Model Through AKT/GSK3β Signaling.

Authors:  Xing-Zhi Guo; Chang Shan; Yan-Fang Hou; Geng Zhu; Bei Tao; Li-Hao Sun; Hong-Yan Zhao; Guang Ning; Sheng-Tian Li; Jian-Min Liu
Journal:  Front Mol Neurosci       Date:  2018-09-27       Impact factor: 5.639

Review 4.  Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from ADH1B, CYP1A2 and MTHFR.

Authors:  Shila Barati; Carlo Fabrizio; Claudia Strafella; Raffaella Cascella; Valerio Caputo; Domenica Megalizzi; Cristina Peconi; Julia Mela; Luca Colantoni; Carlo Caltagirone; Andrea Termine; Emiliano Giardina
Journal:  Genes (Basel)       Date:  2022-08-22       Impact factor: 4.141

5.  Exercise as therapy for Parkinson's?

Authors:  Erin K Crowley; Yvonne M Nolan; Aideen M Sullivan
Journal:  Aging (Albany NY)       Date:  2018-07-20       Impact factor: 5.682

Review 6.  What and How Can Physical Activity Prevention Function on Parkinson's Disease?

Authors:  Baozhu Fan; Riffat Jabeen; Bing Bo; Chunlei Guo; Mengjie Han; Hui Zhang; Juan Cen; Xinying Ji; Jianshe Wei
Journal:  Oxid Med Cell Longev       Date:  2020-02-13       Impact factor: 6.543

Review 7.  Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease.

Authors:  Jing Liu; Fei Xu; Zhiyan Nie; Lei Shao
Journal:  Front Cell Infect Microbiol       Date:  2020-10-22       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.